Back to search

Article

Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinoma

2024-03-05

Abstract excerpt

<h4>Background: </h4> Although sorafenib has been consistently used as a first-line treatment for advanced hepatocellular carcinoma (HCC), most patients will develop resistance, and the mechanism of resistance to sorafenib needs further study. Methods Using KAS-seq technology, we obtained the ssDNA profiles within the whole genome range of 7721 cells treated with sorafenib for differential analysis. We then inter...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ca7c9ca9-b127-5c0f-8199-26cc0bd610da
DOI
10.21203/rs.3.rs-3996234/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinomaDOI 10.21203/rs.3.rs-3996234/v1
Select a neighboring publication to make it the new centre.